VA
Therapeutic Areas
Alpheus Medical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Drug-Ultrasound Combination Therapy | Glioblastoma (GBM), newly diagnosed | Phase 2b |
Leadership Team at Alpheus Medical
IE
Imran Eba
Chief Financial Officer
JL
Jeremy Ling
Chief Technology Officer
AH
Ann-Marie Hulstine
Vice President, Clinical Operations
MP
Mike Preigh, Ph.D
Vice President, Chemistry, Manufacturing & Controls (CMC)
NE
Nick Ellens, Ph.D
Vice President, Research & Development
KV
Klaus Veitinger, MD, Ph.D
Executive Chairman of the Board
JJ
John Johnson
Board Member (HealthQuest Capital)
JM
Juan-Pablo Mas
Board Member (Synapse Fund)
RS
Robert Stein, MD, Ph.D
Board Member (Samsara BioCapital)